Weight & Type 2 Diabetes Study
Helping Daytona Beach patients explore new treatments for weight management and type 2 diabetes through safe, expertly managed clinical studies.
Weight & Type 2 Diabetes Study
About This Study
This research aims to learn whether eloralintide — given regularly — helps people with type 2 diabetes who are overweight or have obesity reduce body weight more than placebo. Participants stay in the study for about 75 weeks and receive regular check-ins to monitor health and progress.
This is a Phase 3, randomized, double-blind, placebo-controlled trial — meaning participants are randomly assigned to receive either eloralintide or placebo.
Adults 18 years or older with type 2 diabetes who are on stable diabetes treatment and have a body mass index (BMI) of 27 kg/m² or higher may be eligible.
Participants must also have had stable body weight in the 90 days before screening.
Everyone continues to receive their regular medical care while in the study.
By taking part in this study, you may contribute to research evaluating a potential new treatment for weight management in adults with type 2 diabetes and overweight or obesity. Participants receive study-related medical care at no cost from our clinical team and may be compensated for time and travel.
Study Eligibility
Who Can Participate?
Age
Adults 18+
Gender
All genders welcome
Condition
Diagnosed with Type 2 Diabetes and has BMI of 27 kg/m² or higher.
Location
Daytona Beach, FL
Enrolling Now
Apply for the Study
Fill out the form below to see if you qualify for our high blood pressure study in Daytona Beach. Participation is completely voluntary, and all study-related care will be provided at no cost to you.
Why Join?
- Access to new treatments before they are widely available
- No cost to participate — insurance is not required
- Compensation for your time and travel
- Personalized medical care from experienced physicians
Study Sponsor
Eli Lilly and Company
Pioneering medicines for diabetes, cardiometabolic, and obesity care
Eli Lilly and Company is a global pharmaceutical leader developing therapies across cardiometabolic disease, oncology, immunology, and neuroscience. Lilly is the sponsor of the muvalaplin and eloralintide clinical programs in development at Arrow.
Why Participate in a Clinical Trial?
Participating in a clinical trial at Arrow Clinical Trials in Daytona Beach is an opportunity to take charge of your health while helping advance medical science — all while under the care of experienced local physicians.
- Access to new treatments before they are widely available
- No cost to participate — insurance is not required
- Compensation for your time and travel
- Personalized medical care from experienced physicians
Daytona General Medicine Clinical Trials
Clinical Trial FAQs
What types of clinical trials does Arrow Clinical Trials offer in Daytona Beach?
We currently conduct research studies in Hypertension, Orthopedics, Cardiology, and Neurology. Our trials include treatments for high blood pressure, joint pain, heart health, stroke recovery, migraines, and other conditions affecting the brain and nervous system.
How long does participation in the study last?
The study lasts about 12 weeks, including screening, treatment, and follow-up visits. The research team will go over the full schedule with you before you decide to participate.
Do I need health insurance to participate?
No. All studies at Arrow Clinical Trials are provided at no cost to participants, and insurance is not required. Any procedures, tests, or study-related care will be covered by the trial sponsor.
Will I be compensated for joining a study?
Yes. Participants may receive compensation for their time and travel. The exact amount depends on the study and the number of visits required.
How do I know if I’m eligible for a trial in Daytona Beach?
Each study has specific requirements, such as age range, medical history, and current health status. Our research team will review your information and conduct a screening process to determine if you qualify.